Liver cirrhosis [LC] is the final evolutive stage of any chronic liver disease and it is a condition prone to multiple complications because of portal hypertension. Development of esophageal varices [EV] is a major complication that may occur in up to 90% of cirrhotic patients. Variceal bleeding occurs in 50%-60% cirrhotic patients. Re-bleeding occurs in 7%-16%, despite endoscopic therapy. Mortality ranges between 3% and 14%. Therefore, endoscopic screening for EV in LC patients is a strong recommendation in all consensus statements. The hypothesis behind this book is to review noninvasive parameters for prediction of EV.
Bitte wählen Sie Ihr Anliegen aus.
Rechnungen
Retourenschein anfordern
Bestellstatus
Storno